Roundtable: Clinical Trials for Essential Thrombocythemia (ET) Patients in the USA
- Peter Löffelhardt
- Jun 19
- 1 min read
The Global MPN Scientific Foundation is hosting a special online roundtable focused on Essential Thrombocythemia (ET) for patients and caregivers in the USA.
With the participation of Prof. Hugh Rienhoff, a renowned expert in genetics, medicine, and MPN innovation, and the real voices of ET patients sharing their personal stories and hopes for the future.
🗓️ Wednesday, June 25th 2025
🕘 9 PM CEST / 3 PM EDT
📍 Online: Zoom
A new clinical trial for ET is currently being developed, and your input matters more than ever. In this session, we will explain what clinical trials are, why they are needed, and how you can help accelerate access to new treatments.
You’ll also connect with others living with ET, exchange experiences, and realize that you are not alone in facing the challenges of this condition.
If you’ve ever wondered how clinical trials work or want to take an active role in shaping the future of ET treatment—this roundtable is for you.
Comments